Analyst Luke Sergott works at BARCLAYS and is focused on the Healthcare sector with 217 price targets and ratings documented since 2021 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 35.52% with an average time for price targets to be met of 54.93 days.
Most recent stock forecast was given on SHC, Sotera Health Company at 15-Nov-2022.
Luke Sergott best performing recommendations are on SHC (SOTERA HEALTH COMPANY).
The best stock recommendation documented was for SHC (SOTERA HEALTH COMPANY) at 11/15/2022. The price target of $6 was fulfilled within 2 days with a profit of $0.97 (13.92%) receiving and performance score of 69.58.
Average potential price target upside